TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
<p>Abstract</p> <p>Background</p> <p>Epigenetic silencing of tumor suppressor genes play important roles in NPC tumorgenesis. Tissue factor pathway inhibitor-2 (TFPI-2), is a protease inhibitor. Recently, <it>TFPI-2 </it>was suggested to be a tumor suppresso...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/617 |
_version_ | 1828814044159541248 |
---|---|
author | Ma Ning Zhang Jinyan Lin Longde Mo Yingxi Yu Nana Du Chunping Huang Tingting Zhou Xiaoying Xiao Xue Wang Shumin Murata Mariko Huang Guangwu Zhang Zhe |
author_facet | Ma Ning Zhang Jinyan Lin Longde Mo Yingxi Yu Nana Du Chunping Huang Tingting Zhou Xiaoying Xiao Xue Wang Shumin Murata Mariko Huang Guangwu Zhang Zhe |
author_sort | Ma Ning |
collection | DOAJ |
description | <p>Abstract</p> <p>Background</p> <p>Epigenetic silencing of tumor suppressor genes play important roles in NPC tumorgenesis. Tissue factor pathway inhibitor-2 (TFPI-2), is a protease inhibitor. Recently, <it>TFPI-2 </it>was suggested to be a tumor suppressor gene involved in tumorigenesis and metastasis in some cancers. In this study, we investigated whether <it>TFPI-2 </it>was inactivated epigenetically in nasopharyngeal carcinoma (NPC).</p> <p>Methods</p> <p>Transcriptional expression levels of <it>TFPI-2 </it>was evaluated by RT-PCR. Methylation status were investigated by methylation specific PCR and bisulfate genomic sequencing. The role of <it>TFPI-2 </it>as a tumor suppressor gene in NPC was addressed by re-introducing <it>TFPI-2 </it>expression into the NPC cell line CNE2.</p> <p>Results</p> <p><it>TFPI-2 </it>mRNA transcription was inactivated in NPC cell lines. <it>TFPI-2 </it>was aberrantly methylated in 66.7% (4/6) NPC cell lines and 88.6% (62/70) of NPC primary tumors, but not in normal nasopharyngeal epithelia. <it>TFPI-2 </it>expression could be restored in NPC cells after demethylation treatment. Ectopic expression of TFPI-2 in NPC cells induced apoptosis and inhibited cell proliferation, colony formation and cell migration.</p> <p>Conclusions</p> <p>Epigenetic inactivation of <it>TFPI-2 </it>by promoter hypermethylation is a frequent and tumor specific event in NPC. <it>TFPI-2 </it>might be considering as a putative tumor suppressor gene in NPC.</p> |
first_indexed | 2024-12-12T10:15:01Z |
format | Article |
id | doaj.art-b824109ce93f481292f17b362284abed |
institution | Directory Open Access Journal |
issn | 1471-2407 |
language | English |
last_indexed | 2024-12-12T10:15:01Z |
publishDate | 2010-11-01 |
publisher | BMC |
record_format | Article |
series | BMC Cancer |
spelling | doaj.art-b824109ce93f481292f17b362284abed2022-12-22T00:27:41ZengBMCBMC Cancer1471-24072010-11-0110161710.1186/1471-2407-10-617TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinomaMa NingZhang JinyanLin LongdeMo YingxiYu NanaDu ChunpingHuang TingtingZhou XiaoyingXiao XueWang ShuminMurata MarikoHuang GuangwuZhang Zhe<p>Abstract</p> <p>Background</p> <p>Epigenetic silencing of tumor suppressor genes play important roles in NPC tumorgenesis. Tissue factor pathway inhibitor-2 (TFPI-2), is a protease inhibitor. Recently, <it>TFPI-2 </it>was suggested to be a tumor suppressor gene involved in tumorigenesis and metastasis in some cancers. In this study, we investigated whether <it>TFPI-2 </it>was inactivated epigenetically in nasopharyngeal carcinoma (NPC).</p> <p>Methods</p> <p>Transcriptional expression levels of <it>TFPI-2 </it>was evaluated by RT-PCR. Methylation status were investigated by methylation specific PCR and bisulfate genomic sequencing. The role of <it>TFPI-2 </it>as a tumor suppressor gene in NPC was addressed by re-introducing <it>TFPI-2 </it>expression into the NPC cell line CNE2.</p> <p>Results</p> <p><it>TFPI-2 </it>mRNA transcription was inactivated in NPC cell lines. <it>TFPI-2 </it>was aberrantly methylated in 66.7% (4/6) NPC cell lines and 88.6% (62/70) of NPC primary tumors, but not in normal nasopharyngeal epithelia. <it>TFPI-2 </it>expression could be restored in NPC cells after demethylation treatment. Ectopic expression of TFPI-2 in NPC cells induced apoptosis and inhibited cell proliferation, colony formation and cell migration.</p> <p>Conclusions</p> <p>Epigenetic inactivation of <it>TFPI-2 </it>by promoter hypermethylation is a frequent and tumor specific event in NPC. <it>TFPI-2 </it>might be considering as a putative tumor suppressor gene in NPC.</p>http://www.biomedcentral.com/1471-2407/10/617 |
spellingShingle | Ma Ning Zhang Jinyan Lin Longde Mo Yingxi Yu Nana Du Chunping Huang Tingting Zhou Xiaoying Xiao Xue Wang Shumin Murata Mariko Huang Guangwu Zhang Zhe TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma BMC Cancer |
title | TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma |
title_full | TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma |
title_fullStr | TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma |
title_full_unstemmed | TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma |
title_short | TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma |
title_sort | tfpi 2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma |
url | http://www.biomedcentral.com/1471-2407/10/617 |
work_keys_str_mv | AT maning tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT zhangjinyan tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT linlongde tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT moyingxi tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT yunana tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT duchunping tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT huangtingting tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT zhouxiaoying tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT xiaoxue tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT wangshumin tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT muratamariko tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT huangguangwu tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma AT zhangzhe tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma |